臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

???ui.leftmenu.abouttair???
	???ui.leftmenu.explanation???

???ui.leftmenu.bartitle???
	Repositories
	Author
	Title
	Date
	???ui.leftmenu.statisticschart???
	???ui.leftmenu.realtimefacts???
	???ui.leftmenu.trend???

???index.news???
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

???ui.leftmenu.copyrighttitle???
	???ui.leftmenu.copyrightpublisher???
	???ui.leftmenu.copyrightconference???

???ui.leftmenu.link???
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"高銘欽 ming ching kao"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1???	???jsp.browse.items-by-author.order2???

Showing items 91-115 of 135 (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page

Institution	Date	Title	Author
中國醫藥大學	2005-07-31	卵巢癌基因治療--微脂粒媒介病毒核抗原抑制卵巢癌患者癌細胞生長之動物試驗	劉嘉燿(Jha-Yao Liu); 高銘欽(Ming-Ching Kao)
中國醫藥大學	2005-07-31	Gene chip approach to the molecular mechanism of repression of HER2/neu by the N-terminal domain of SV40 large T antigen	高銘欽(Ming-Ching Kao); 姜淑媛(Su-Yuan Jiang)
中國醫藥大學	2005-07	Nitric oxide induces prion protein via MEK and p38 MAPK signaling	(Wang V); (Chuang TC); (Hsu YD); (Chou WY); 高銘欽(Ming-Ching Kao)*
中國醫藥大學	2005-04-16	Human MnSOD suppresses HER2/neu-mediated breast cancer malignancy	高銘欽(Ming-Ching Kao)*; 莊子超(Tzu-Chao Chuang); 湯雅婷(Ya-Ting Tan); 林彥杏(Yeng-Shing Lin); 劉嘉燿(Jia-Yaw Liu); 林棋財(Chi-Tsai Lin)
中國醫藥大學	2005-04	Clinicopathological relevance of HER2/neu and a related gene-protein cubic regression correlation in colorectal adenocarcinomas in Taiwan	(Li JW); (Chuang TC); (Yang AH); (Hsu CK); 高銘欽(Ming-Ching Kao)*
中國醫藥大學	2005-02	Skeletal muscle dihydropyridine-sensitive calcium channel (CACNA1S) gene mutations in chinese patients with hypokalemic periodic paralysis	(Lin SH)*; (Hsu YD); (Cheng NL); 高銘欽(Ming-Ching Kao)
中國醫藥大學	2005-01	Degradation of HER2/neu by apigenin induces apoptosis through cytochrome c release and caspase-3 activation in HER2/neu-overexpressing breast cancer cells	魏宗德; 高銘欽(Ming-Ching Kao); (Lin JK)
中國醫藥大學	2004-12-31	台灣本土栽培靈芝在抗癌保健作用的效益評估	高銘欽(Ming-Ching Kao)
中國醫藥大學	2004-11-09	Oncogene-targeting cancer gene therapy	高銘欽(Ming-Ching Kao)*
中國醫藥大學	2004-09	Black tea polyphenol theaflavins inhibit aromatase activity and attenuate tamoxifen resistance in HER2/neu-transfected human breast cancer cells through tyrosine kinase suppression.	魏宗德; (Lee HH); 高銘欽(Ming-Ching Kao); (Lin JK)
中國醫藥大學	2004-07-31	Gene chip approach to the molecular mechanism of repression of HER2/neu by the Epstein-Barr virus nuclear antigen-1	高銘欽(Ming-Ching Kao)
中國醫藥大學	2004-06-12	Suppression of HER2/neu by superoxide dismutase in breast cancer MDA-MB-453 cells	高銘欽(Ming-Ching Kao)*; 莊子超(Tzu-Chao Chuang); 湯(Ya-Ting Tan); 林(Yeng-Shing Lin); 林棋財(Chi-Tsai Lin)
中國醫藥大學	2004-02	Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway	魏宗德(Tzong-Der Way); 高銘欽(Ming-Ching Kao); 林仁混(Lin JK)*
中國醫藥大學	2003-11-07	The N-terminal domain only of EBNA1 as a tumor suppressor	高銘欽(Ming-Ching Kao)*; 莊子超(Tzu-Chao Chuang); 胡誌麟(Chih-Lin Hu); 林彥杏(Yeng-Shing Lin); 劉嘉燿(Jia-Yaw Liu); 羅世農(Sai-Lung Law)
中國醫藥大學	2003-08	EBNA1 may prolong G2/M phase and sensitize HER2/neu-overexpressing ovarian cancer cells to both topoisomerase II-targeting and paclitaxel drugs	(Chuang TC); (Lee YJ); (Liu JY); (Lin YS); (Lee JW); (Wang V); (Law SL); 高銘欽(Ming-Ching Kao)*
中國醫藥大學	2003-08	EBNA1 may prolong G(2)/M phase and sensitize HER2/neu-overexpressing ovarian cancer cells to both topoisomerase II-targeting and paclitaxel drugs	(Chuang TC); (Lee YJ); (Liu JY); (Lin YS); (Li JW); (Wang V); (Law SL); 高銘欽(Ming-Ching Kao)*
中國醫藥大學	2003-07-31	Evaluation of cancer gene therapy using the N-terminal domain of SV40 large T antigen through transgenic technology	高銘欽(Ming-Ching Kao)
中國醫藥大學	2003-05	Two novel thiazide-sensitive Na-Cl cotransporter mutations in a Chinese patient with Giteman's Syndrome presenting as hypokalemic paralysis	(Cheng NL); 高銘欽(Ming-Ching Kao); (Hsu YD); (Lin SH)*
中國醫藥大學	2002-11-17	The N-terminal domain only of EBNA1 may act as atransforming suppressor of theHER2/neu oncogene in ovarian cancers	高銘欽(Ming-Ching Kao)*
中國醫藥大學	2002-11	The Epstein–Barr virus nuclear antigen-1 may act as a transforming suppressor of the HER2/neu oncogene	(Chuang TC); 魏宗德; (Lin YS); (Lee YC); (Law SL); 高銘欽(Ming-Ching Kao)*
中國醫藥大學	2002-07-31	Evaluation of cancer gene therapy using the N-terminal domain of SV40 large T antigen through transgenic technology	高銘欽(Ming-Ching Kao)
中國醫藥大學	2002-04-06	The N-terminal domain of SV40 large T antigen may act as both transformation and metastasis suppressors in HER2/neu-overexpressing breast cancer cells	高銘欽(Ming-Ching Kao)*; 莊子超(Tzu-Chao Chuang); 游玉華(Yu-Hua Yu); 林彥杏(Yeng-Shing Lin); 王盛世(Shen-Shue Wang)
中國醫藥大學	2002-01	The N-terminal domain of SV40 large T antigen represses the HER2/neu-mediated transformation and metastatic potential in breast cancers	(Chuang TC); (Yu YH); (Lin YS); (Wang SS); 高銘欽(Ming-Ching Kao)*
中國醫藥大學	2001-11-19	The N-terminal domain only of the Epstein-Barr virus nuclear antigen-1 may act as ta transforming suppressor of the HER2/neu oncogene	高銘欽(Ming-Ching Kao)*; 莊子超(Tzu-Chao Chuang); 胡誌麟(Chih-Lin Hu); 林彥杏(Yeng-Shing Lin); 羅世農(Sai-Lung Law)
中國醫藥大學	2001-11-03	Repression of HER2/neu-mediated transformation and metastatic potential by the N-terminal domain of SV40 large T antigen in breast cancers	莊子超(Tzu-Chao Chuang); 游玉華(Yu-Hua Yu); 林彥杏(Yeng-Shing Lin); 羅世農(Sai-Lung Law); 高銘欽(Ming-Ching Kao)*

Showing items 91-115 of 135 (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page

	English \| 正體中文 \| 简体中文 \| 2832487
	???header.visitor??? : 33865502 ???header.onlineuser??? : 1371 ???header.sponsordeclaration???